38.06 USD
↗ 1.38 (3.76%)AT CLOSE (03:59 PM EDT)
Axogen, Inc. Common Stock
AXGNNASDAQ • USD
38.08
↗ 0.02 (0.04%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
38.08
↗ 0.02 (0.04%)
Market: CLOSED
Axogen, Inc. Common Stock (AXGN) trades at $38.06 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 23, 2026.
Open?$36.64
High?$38.33
Low?$36.60
Prev. Close?$36.68
Volume?2.1M
Avg. Volume?1.4M
VWAP?$37.88
Rel. Volume?1.54x
Bid / Ask
Bid?$29.51 × 100
Ask?$50.73 × 100
Spread?$21.22
Midpoint?$40.12
Valuation & Ratios
Market Cap?2.2B
Shares Out?53.8M
Float?50.4M
Float %?93.8%
P/E Ratio?N/A
P/B Ratio?8.71
EPS?-$0.57
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
Employees
622
Market Cap
2.2B
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Website
Listed
1986-12-17
Address
13631 PROGRESS BLVD.
ALACHUA, FL 32615
Phone: (386) 462-6817
ALACHUA, FL 32615
Phone: (386) 462-6817
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?100
Momentum?69
Short Sent.?50
Piotroski F-Score?3/9Weak
Altman Z-Score?27.41Safe
Confidence?57%Low
Short InterestElevated
Short % of Float?9.31%Elevated
Short Interest?4.7M
Days to Cover?4.2
Free Float50.4M
Avg Daily Volume1.1M
Settlement Date2026-09-30
Financial Health
Current Ratio?6.60Strong
Quick Ratio?5.04Strong
Cash Ratio?3.11Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score47/100
P/E?N/A▾
P/B?8.71HIGH▾
Peers100
S&P22
P/S?8.89HIGH▾
Peers100
S&P10
P/FCF?259.7PRICEY▾
Peers100
S&P3
EV/EBITDA?-358.3CHEAP▾
S&P97
EV/Sales?8.51HIGH▾
Peers100
S&P15
Returns & Efficiency
ROE?-13.1%WEAK▾
S&P9
ROA?-11.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$8.6M
Enterprise Value?$2.1B
Fundamentals ratios updated end of day